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ORIGINAL ARTICLE
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uptake of toxic amine modified nanoparticles
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Abstract
The lung provides the main route for nanomaterial exposure. Surfactant protein A (SP-A) is an
important respiratory innate immune molecule with the ability to bind or opsonise pathogens
to enhance phagocytic removal from the airways. We hypothesised that SP-A, like surfactant
protein D, may interact with inhaled nanoparticulates, and that this interaction will be affected
by nanoparticle (NP) surface characteristics. In this study, we characterise the interaction of SP-A
with unmodified (U-PS) and amine-modified (A-PS) polystyrene particles of varying size and
zeta potential using dynamic light scatter analysis. SP-A associated with both 100 nm U-PS and
A-PS in a calcium-independent manner. SP-A induced significant calcium-dependent agglom-
eration of 100 nm U-PS NPs but resulted in calcium-independent inhibition of A-PS self
agglomeration. SP-A enhanced uptake of 100 nm U-PS into macrophage-like RAW264.7 cells in
a dose-dependent manner but in contrast inhibited A-PS uptake. Reduced association of A-PS
particles in RAW264.7 cells following pre-incubation of SP-A was also observed with coherent
anti-Stokes Raman spectroscopy. Consistent with these findings, alveolar macrophages (AMs)
from SP-A/ mice were more efficient at uptake of 100 nm A-PS compared with wild type
C57Bl/6 macrophages. No difference in uptake was observed with 500 nm U-PS or A-PS
particles. Pre-incubation with SP-A resulted in a significant decrease in uptake of 100 nm A-PS in
macrophages isolated from both groups of mice. In contrast, increased uptake by AMs of U-PS
was observed after pre-incubation with SP-A. Thus we have demonstrated that SP-A promotes
uptake of non-toxic U-PS particles but inhibits the clearance of potentially toxic A-PS particles
by blocking uptake into macrophages.
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Introduction
The ability of nanotechnology to produce engineered nanoparti-
cles (NPs) of various shapes and materials has opened up new
applications in areas such as medicine, engineering, electronics,
textiles and cosmetics. The number of consumer products
containing NPs is rapidly increasing and is now counted in
thousands (Nanotechnologies, 2014). This reflects the unique and
diverse properties of nanomaterials, which can be very different
from the bulk material due, in part, to their enhanced surface to
mass ratio (Oberdo¨rster et al., 2005a).
Exposure to nanomaterials is not a new phenomenon.
Throughout evolution, humans have been exposed to nanosized
particles from both biogenic and anthropogenic sources.
However, human lung exposures have risen dramatically due to
anthropogenic emission from diesel engines, power stations and
engineering processes optimised for manufacturing nanoscale
materials (Oberdo¨rster et al., 2005b). Due to the small size of
nanomaterials, they are often airborne and have the capability of
reaching the alveolar compartment of the lungs (Oberdo¨rster
et al., 2002, 2005b). Once inside the airways, the NPs can be
adsorbed onto the mucosal surface in the upper airways and into
surfactant lining the lower airways. A nano-bio corona of
biological molecules then forms on the NP surface, which can
in turn influence the clearance, bioavailability and potential
toxicity of the NPs (recently reviewed in Kendall & Holgate
(2012)).
Pulmonary surfactant is a multi-layered lipoprotein substance,
comprising approximately 90% lipids and 10% protein, and lines
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the alveolar epithelium at the air liquid interface. Pulmonary
surfactant performs two vital functions in the lung; reducing
alveolar surface tension and protecting the lung from microbial
infection (reviewed in Pe´rez-Gil (2008)). Surfactant protein
A (SP-A) and its sister protein surfactant protein D (SP-D) are
both hydrophilic proteins found in surfactant belonging to the
calcium-dependent (C-type) lectin sub-family known as ‘‘collec-
tins’’ (collagenous lectins). Collectins are oligomeric proteins
made up of trimeric units. The trimeric units are composed of
three monomers, each with its own carbohydrate recognition
domain (CRD) containing the lectin activity (Figure S1). The
trimeric units are characterised by four structural domains: an
amino terminus (where the oligomerisation between trimeric units
take place), a collagenous domain, a neck region and the CRD
region. Six of these trimeric units oligomerise to form
octadecamers, the native form of SP-A (Figure S1). As SP-A
has a bend in the collagenous region, the quaternary structure has
been described as a ‘‘bunch of tulips’’ similar to the complement
C1q molecule (Voss et al., 1988). Four trimeric units come
together to form SP-D in the shape of a cross (Figure S1). SP-A is
the most abundant of the two proteins with approximately 10
times more SP-A in surfactant than SP-D (Pastva et al., 2007).
The pulmonary collectins, SP-A and SP-D, play an important role
in the innate immune defence of the lung; they are pattern
recognition molecules and are able to protect the lung from
infection through a variety of mechanisms. They recognise and
bind specific carbohydrate moieties on the surface of micro-
organisms via the CRD and can facilitate microbial clearance
through agglutination and opsonisation (reviewed in Pastva et al.
(2007)). They also promote uptake and clearance of dead and
dying apoptotic cells in the airway and bind to cell-surface
exposed and free DNA debris (Clark et al., 2002; Palaniyar et al.,
2003). Both SP-A and SP-D rapidly promote microbial uptake
into phagocytes and have anti-inflammatory effects by inhibiting
cytokine and chemokine responses of phagocytes and lympho-
cytes after initial infection. Phagocytosis is believed to keep the
phagocytosed material contained and the lung in an inflamma-
tion-free and quiescent state for optimal lung function (Brinker
et al., 2003; Borron et al., 1996, 1998, 2000; Hansen et al., 2007).
In vivo studies with mice deficient for SP-A (SP-A/ mice) have
shown that SP-A is important for the phagocytosis and clearance
of both bacteria and viruses from the lung (LeVine et al., 1997,
1998, 1999a,b, 2002; Li et al., 2002). Recent studies have
suggested that SP-A and SP-D also play a role in the clearance of
non-infectious particulate matter in the lung (Kendall et al., 2013;
Ruge et al., 2011, 2012).
We have previously characterised the interaction of SP-D with
various NPs including unmodified (U-PS) and amine (A-PS)
surface-modified polystyrene particles (Kendall et al., 2013).
SP-D co-localised to 200 nm A-PS NPs in A549 epithelium cells
in vitro (Kendall et al., 2013). Furthermore, alveolar macrophages
(AMs) from wild type (WT) C57Bl/6 mice showed enhanced
uptake of both 100 nm and 500 nm U-PS and A-PS particles
compared with AMs isolated from mice deficient in SP-D
(SP-D/ mice) (Kendall et al., 2013). Addition of exogenous
SP-D to AMs from SP-D/ mice enhanced the percentage of
AMs taking up 100 nm A-PS (Kendall et al., 2013). Both SP-A
and SP-D have been found to bind to carbon nanotubes (Salvador-
Morales et al., 2007). The binding was calcium-dependent and
was variable between batches of nanotubes indicating that the
binding was mediated by surface impurities or chemical modi-
fications of the nanotubes (Salvador-Morales et al., 2007).
Differential interaction of SP-A was also observed with metal
oxide NPs, including titanium oxide and cerium oxide particles,
where differences were seen with different surface-modified
particles derived from the same bulk-material highlighting the
importance of the particle size, surface charge and chemistry
(Schulze et al., 2011). SP-A has also been found to bind to certain
surface-modified magnetic NPs (Ruge et al., 2011). It was shown
that SP-A specifically interacted with magnetic NPs modified
with starch, carboxymethyldextran, chitosan, poly-maleic-oleic
acid and phosphatidylcholine compared with bovine serum
albumin (BSA) (Ruge et al., 2011). SP-A also enhanced the
association of the surface-modified magnetic particles to AMs,
except for starch, when compared with BSA. Furthermore, SP-A
increased the uptake of phosphatidylcholine NPs into AMs,
whereas the presence of BSA resulted in a decrease in particles
taken up by the cells (Ruge et al., 2011). SP-A was also found to
facilitate the uptake of aggregated NP-sized tacrolimus complexes
(an immunosuppressive agent) into human macrophage-like U937
cells.
In this study, we characterise the interaction of SP-A with
polystyrene NPs with well-defined different surface characteris-
tics and size. As in previous studies with SP-D, we focused on
U-PS and A-PS at 100, 200 and 500 nm. We characterised the
effect of SP-A on uptake of NPs in the murine macrophage cell
line, RAW264.7, before extending the results into primary AMs
isolated from SP-A-deficient mice and C57Bl/6 wild type control
mice. The effects of interaction of SP-A and NPs are distinct from
our previous report for SP-D.
Materials and methods
Nanoparticles
Polystyrene particles with and without surface modification
with sizes of 100 nm, 200 nm and 500 nm were purchased
(Polysciences Inc, Northampton, UK or Sigma-Aldrich, Dorset,
UK). The particles were unmodified polystyrene (U-PS), amine-
modified polystyrene (A-PS) and carboxylate-modified polystyr-
ene (C-PS). Fluorescent green 100 nm U-PS and fluorescent
orange 100 nm A-PS were purchased from Polysciences and
Sigma-Aldrich, respectively.
SP-A purification
Human bronchoalveolar lavage (BAL) was obtained from patients
with written informed consent undergoing lung washings for
therapeutic purposes including pulmonary alveolar proteinosis.
The procedure was approved by the London National Health
Service Research Ethics Committee (NRES reference 10/H0504/
9). Native human SP-A was purified from the SP-A-rich BAL
pellet either by gel chromatography or butanol extraction as
described previously (Suwabe et al., 1996; Wright et al., 1987).
The purity of SP-A was verified by sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE), Western blot-
ting and N-terminal sequencing. The purified SP-A protein was
diluted with nanopure water or Tris-buffered saline (TBS) with
2–5 mM calcium before mixing with particles.
Characterisation of the NP and SP-A interaction by
dynamic light scatter analysis and zeta potential
The interaction between SP-A and NPs was characterised by
dynamic light scatter (DLS; HPPS and Zetasizer Nano ZS,
Malvern Instruments, Worcestershire, UK) and zeta potential (ZP;
Zetasizer Nano ZS, Malvern Instruments). This was initially
performed in nano pure water as described previously (Kendall
et al., 2013). The DLS and ZP analyses were also performed in
TBS and serum-free (SF) RPMI-1640 medium without phenol
red (Gibco, Life Technologies, UK). In these experiments, A-PS
or U-PS particles were suspended in TBS with 5 mM calcium at a
concentration of 12.5 cm2/mL. These particles were diluted with
equal volumes of protein (SP-A or BSA) suspended in
DOI: 10.3109/17435390.2014.992487 SP-A and NPs 953
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TBS + calcium at 50 mg/mL. The size and ZPs of these suspen-
sions were measured immediately before (T-2) and after (T0) the
addition of protein. The particle suspensions were then incubated
at 37 C for 48 min, the size and ZP were then measured before
(T48) and after (T60) the addition of SF RPMI. This yielded a
TBS/RPMI ratio of 2:3 and final concentrations of proteins and
particles of 10 mg/mL and 2.5 cm2/mL, respectively. The size and
ZP of the suspensions were measured again following incubation
for a further two hours at 37 C (T180). All measurements were
conducted at 37 C using reusable or disposable capillary cells
(Malvern Instruments).
RAW cells
RAW264.7 cells are a mouse macrophage-like cell line estab-
lished from murine tumours induced with Abelson leukaemia
virus (Raschke et al., 1978). Cells were routinely grown in RPMI-
1640 (Gibco) supplemented with 1% L-glutamine (Gibco), 1%
penicillin/streptomycin (Gibco) and 10% heat-inactivated foetal
calf serum (Sigma-Aldrich) at 37 C in a humidified atmosphere
with 5% CO2. The semi-adherent cell line was routinely sub-
cultured using a cell scraper every third day.
Uptake of unlabelled A-PS NPs
RAW264.7 cells were scrapped and plated in six-well plates on
sterile cover slips with 500 000 cells/well. The cells were allowed
to adhere for 24 hours, and then the cells were incubated with
5mL of NPs (in general 1013 NPs/mL corresponding to 5 1010
NP/well) in a total volume of 1 mL SF RPMI medium for two
hours. The cells were washed carefully with phosphate-buffered
saline (PBS) twice and then fixed in 1% paraformaldehyde in PBS
for one hour at room temperature. The cover slips, with attached
cells, were mounted on a glass side upside down and the edges
sealed with clear nail polish. The slides were then analysed using
Coherent anti-Stokes Raman scattering (CARS).
Uptake of fluorescent A-PS and U-PS particles
in RAW cells
Aliquots of 100 nm fluorescent orange A-PS or fluorescent green
U-PS particles were mixed with SP-A in TBS containing 5 mM
calcium to yield concentrations of 9.4 cm2/mL particles and
25mg/mL proteins. Particle–protein suspensions were incubated
for one hour at 37 C in 96-well round bottom plates. RAW264.7
cells were washed three times in SF RPMI and dissociated from
culture flasks using a cell scraper. Cells were suspended in SF
RPMI at a concentration of 1.67 106 cells/mL, and 30 mL
aliquots were added to each well yielding a final particle
concentration of 3.75 cm2/mL and a TBS/RPMI ratio of 2:3.
The cells were incubated for one hour at 37 C in a humidified
atmosphere. The cells were washed once in 1 mL PBS and
centrifuged at 400 g for 10 min to remove excess particles. The
cells were resuspended in 40 mL PBS and kept on ice prior to
analysis. Trypan blue was added to the cells immediately before
the analysis of 5000 cells per sample using flow cytometry (BD
FACSAria, BD Biosciences, Oxford, UK).
CARS analysis
CARS microscopy is a label-free chemical imaging technique,
which generates contrast using molecular vibrations, which are
specific to an individual molecule (Patel et al., 2013). A home-
built CARS setup comprising of a Chameleon (Coherent) and
Compact OPO (APE Berlin) coupled to an inverted Nikon Ti-U
2000 microscope (Nikon, Kingston upon Thames, UK) was used
to acquire images. The beams were temporally overlapped using a
delay stage and combined to form a spatially overlapped collinear
beam. The pump beam was set to 835 nm, and the Stokes beam
from the OPO was tuned to target the Raman frequency of
2850 cm–1 to target the CH2 stretching band. Due to the higher
concentration of CH2 bonds in polystyrene beads and the fact that
CARS has a quadratic dependence on the number of oscillators,
the PS beads offer high contrast to enable qualitative and
quantitative analysis. Amine-modification of the surface of a
polystyrene bead will not affect the bulk of the –CH2 CARS signal
(at 2850 cm1) from the 200 and 500 nm beads used in this work
and changes, if any, are well within the spectral resolution of the
system.
A series of images was taken for every time point and each
individual cell sample. Dwell times of 30 ms were usually chosen,
and an area of 30 mm 30 mm scanned at 1024 1024 pixels to
generate a highly resolved image. Images were acquired with a
40 (NA: 1.2) water-immersion objective (Nikon). Four images
were acquired at random on cell areas on the glass coverslip for
each separate treatment. In separate experiments to characterise
the spatial (lateral) resolution of the CARS microscope, particles
of various sizes (100–1000 nm) were imaged. It was found that
200 nm sized PS particles were resolvable and hence, the
quantitative analysis based on CARS was carried out 200 nm
particles. At the above target vibrational frequency of 2850 cm1,
the PS particles showed up as highly CARS-active areas, which
were quantified using a code written in MATLAB (MathWorks,
Cambridge, UK). The number of pixels with intensities exceeding
a certain threshold (defined by the background) was counted. This
area contributing to the signal is related directly to the number of
NPs due to the nature of the CARS signal generation process
(multiphoton and hence, inherently confined to the focal plane),
and the images presented in this work are 2D rather than 3D
projections/stacks. This number corresponding to the bright areas
was compared with the overall cell area in pixels to obtain a ratio
of NP over cell area.
Mouse BAL and isolation of AMs
Wild type (WT) C57Bl/6 mice and SP-A-deficient mice (SP-A/;
Li et al., 2002), back-crossed at least 10 times onto the C57Bl/6
mouse background, were housed in specific pathogen-free housing
at the Biomedical Research Facility at the University of
Southampton. Mice received sterile rodent chow and water ad
libitum with a 12-hour light and dark cycle. All animal procedures
were approved by university local animal ethics committee and the
Home Office, UK. The mice were sacrificed by CO2 asphyxiation
prior to cannulation of the trachea with a fine bore cannula. The
BAL was performed by instillation and withdrawal of 3 1 mL of
PBS with 0.5 mM EDTA, which was subsequently pooled. Cells
were pelleted by centrifugation at 300 g for 10 min. The cell pellet
was re-suspended in SF RPMI. Differential cell counts on cytospin
preparations after staining with Diff-Quick (Scientific Products,
McGaw Park, IL) confirmed that more than 95% of the cells
isolated this way were AMs.
AM uptake of fluorescent microspheres
The NPs used in the ex vivo experiments were either 100 nm or
500 nm U-PS (Sigma-Aldrich) or A-PS (Sigma-Aldrich) and were
labelled with green fluorescent dye (fluorescein isothiocyanate
(FITC), Sigma-Aldrich) dissolved in carbonate buffer (Sigma-
Aldrich) at pH 9.6 at a concentration of 1 mg/mL. The FITC was
then diluted 1:10 in nanopure water containing the NPs and
incubated at room temperature for one hour with rotation. The
NPs were centrifuged for 10 min at 20 937 g and washed twice
with nanopure water. We have previously shown that the coupling
of FITC to the NPs by this methodology only provides minimal
leaching at pH 7.4 and 4.0, to mimic the conditions of the
954 Z. McKenzie et al. Nanotoxicology, 2015; 9(8): 952–962
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extracellular and endosomal environments, respectively (Kendall
et al., 2013). AMs were isolated from C57Bl/6 and SP-A/ mice
as described above, the cells were washed and then incubated with
NPs (1:5; 25 000 cells:125 000 NPs), after 5 min sonication, at
37 C for 30 min. The cells were centrifuged at 300 g for 10 min
and washed three times with RPMI (Gibco) to remove excess
beads and re-suspended in cytofix (BD Biosciences) containing
0.2% trypan blue to quench extracellular fluorescence as previ-
ously described (Hartshorn et al., 1994). The fixed cells were then
analysed by fluorescence-activated cell sorting (FACS).
The effects of SP-A on AM uptake of Fluorescent
Microspheres
Fluorescent A-PS (Sigma-Aldrich) or U-PS 100 nm NPs
(Polysciences) were used to determine the effects of exogenous
SP-A on NP uptake in AMs isolated from C57Bl/6 wild type and
SP-A/ mice as described above. NPs were prepared as
described in the section for the ‘‘Uptake of fluorescent A-PS
and U-PS particles in RAW cells’’ and incubated for 90 min at
37 C, 5% CO2; 17 000 AMs in colourless RPMI were added to
the SP-A/NP preparation and incubated for a further 90 min at
37 C, 5% CO2. Cells were then washed with PBS with 1% BSA
and 5 mM EDTA (FACS buffer) and centrifuged at 400 g for
10 min to remove excess particles. The cells were then re-
suspended in FACS buffer containing 0.2% trypan blue for FACS
analysis.
FACS analysis
The FACS analysis was performed on a FACS Aria machine (BD
Biosciences). Both forward and side-scatter threshold values were
set to 200 to exclude free beads and cell debris from the analyses.
Between 5000 and 10 000 cells were counted for each sample.
The cells that contained beads (FL-1450) were counted
through gating and analysed using BD FACSDiva software,
v4.3 (BD Biosciences).
Statistical analysis
Collected data were normal distributed, and the parametric
unpaired t-test with the Holm–Sidak method was used for
testing between two groups, and ANOVA (with Bonferroni
post hoc test) was used to test results between multiple groups.
Data were analysed using SPSS version 20 (IBM SPSS
Statistics, Portsmouth, UK) or GraphPad Prism, version 6
(La Jolla, CA). Results were considered statistically significant
when p50.05.
Results
We have previously measured the size distributions and ZP of
a range of similarly sized polystyrene particles (A-PS, C-PS and
U-PS), silicone particles (200 V and R816) and carbon black
particles (CB400R) in water over time with the addition of
purified human SP-D (Kendall et al., 2013). These results showed
that SP-D interacted differently with these particles. In this study,
we present the interaction of A-PS and U-PS particles with
purified human SP-A.
The size distribution of purified human SP-A in water was
measured by light intensity and number. The SP-A preparation
was polydispersed with two peaks between 10 and 500 nm. A few
macromolecules were also evident in this preparation with a small
peak around 4500 nm. The majority of the human SP-A, measured
by number of particles, showed a median of 30 nm in size (Figure
S2). The ZP of SP-A alone in water was 11.8 mV.
In order to fully characterise the effect of SP-A on particle size
and ZP, these measurements were taken in nanopure water and the
media used for cell experiments (i.e. TBS/RPMI). First, we
examined the hydrodynamic size and ZPs of A-PS and U-PS
particles in nanopure water without calcium with and without the
addition of SP-A (Table S1). In nanopure water, A-PS particles
had a strong positive (+60 mV) ZP, which became negative with
the addition of SP-A (22.8 mV). U-PS particles had a ZP of
38.5 mV, which moved closer to zero following the addition of
SP-A (18.7 mV). The z average increased for both A-PS (49.1%)
and U-PS (14.3%) particles when incubated with SP-A for
1440 min (Table S1).
The extent of the increase in the z average for 100 nm U-PS
particles when incubated with SP-A for 24 hours is indicative of
the formation of a protein corona rather than particle agglomer-
ation. Calcium is essential for the lectin activity of SP-A as the ion
is involved in the coordination of several of the amino acid
residues involved in binding to carbohydrates (Head et al., 2003).
We therefore investigated the effect of calcium concentration on
the agglomeration rate of 100 nm U-PS particles within a range of
0–2 mM to elucidate if the CRD in SP-A could be involved in
agglomeration. The results showed that the agglomeration rate of
U-PS depended on the calcium concentration with the addition of
2 mM of calcium required for SP-A-mediated agglomeration to
occur (Figure S3B). When the calcium concentration was 1 mM
or lower, agglomeration of U-PS particles in the presence of SP-A
was not observed. In the presence of 2 mM calcium, SP-A
agglomerated the U-PS particles within 10 min, and the agglom-
erates increased in size over time (Figure S3C). Based on these
results, a minimum concentration of 2 mM CaCl2 was used in the
following experiments.
In order to maintain the calcium concentration above 2 mM at
all stages of the in vitro cellular experiments, the particles were
pre-incubated with SP-A in TBS containing 5 mM calcium before
the addition of cells suspended in SF RPMI media. The
proportion of TBS to RPMI used in the experiments (2:3) was
pre-determined not to cause precipitation of calcium – which
occurred following the addition of 2 mM calcium directly to
RPMI. The size and ZPs were measured in TBS or TBS/RPMI
at various time points (T-2 to T180). These results are listed in
Table 1 and Figures 1 and 2. The time points chosen reflect the
incubation periods for the in vitro cellular experiments. Size and
ZP were measured in TBS + Ca immediately before (T-2) and
after (T0) the addition of protein. The particle–protein suspen-
sions were incubated at 37 C and the size distributions and ZP
measured before (T48) and after (T60) the addition of RPMI. This
incubation period reflected the pre-incubation of particles and
proteins before the addition of cells. The particle suspensions
were incubated again for a further two hours to reflect the
incubation period with the cells (T180).
Interestingly, the incubation of A-PS particles in TBS/RPMI
(T60) resulted in the self agglomeration of the particles at
physiological temperatures (i.e. 37 C); pre-incubation with SP-A
resulted in a reduction in the A-PS particle self agglomeration at
this temperature. BSA also inhibited this self agglomeration
(Figure 1A and Table 1). The particle size distributions show that
SP-A reversed the self agglomeration of A-PS particles over time
(Figure 1B). However, this did not seem to be the case when
examining the Z-average of the particles (Table 1). This may be
related to the high polydispersity of the samples and the presence
of a few large agglomerates skewing the z average. The incubation
of SP-A with U-PS particles for 60 min at 37 C greatly enhanced
the particle size (Figure 1C). The incubation of BSA with U-PS
particles resulted in a slight increase in the size of the majority of
particles and the generation of a small number of larger particle
agglomerates around 500 nm in size. At T180 U-PS particles had
begun to self agglomerate, a process which was inhibited in the
presence of BSA. This was evident by examining both the z
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average and the size distribution by number. RPMI promoted the
agglomeration of both particles (see Table 1).
A-PS particles had a positive ZP in TBS with calcium, which
reduced slightly over time at 37 C. The addition of RPMI to the
A-PS particles resulted in a negative ZP (Table 1). The addition of
SP-A or BSA to the A-PS particles also resulted in negative ZPs
(Table 1). The U-PS particle ZP became closer to zero over
time and following the addition of RPMI (Table 1). The addition
Figure 1. Dynamic light scattering analysis of the size distributions of 100 nm A-PS and U-PS particles in TBS/RPMI. Size distributions of 100 nm
A-PS (A and B) and 100 nm U-PS (C and D) nanoparticles in TBS-RPMI; 12.5 cm2/mL of particles in TBS with 5 mM Ca2+ were mixed with 50 mg/mL
BSA (g) or 50 mg/mL SP-A (m) or TBS only () for one hour before being mixed with RPMI (TBS:RPMI; 2:3) and their size distributions
immediately measured at 37 C (A and C, T60) and again two hours later (B and D, T180). The final protein concentration was 10mg/mL, and
nanoparticle concentrations were 2.5 cm2/mL. Size distributions of nanoparticles in TBS only at T-2 are shown as dashed line.
Table 1. Hydrodynamic size and zeta potential of A-PS and U-PS particles following incubation with SP-A or BSA.
Control SP-A BSA
Media (time
point, min)
Z-AVE
(d, nm)
Dd
(%)a PDI
ZP
(mV)
Z-AVE
(d, nm) Dd (%)a PDI
ZP
(mV)
Z-AVE
(d, nm) Dd (%)a PDI
ZP
(mV)
NP
A-PS TBS (T-2) 109.7 – 0.123 +24.4 109.7 – 0.123 +24.4 109.7 – 0.123 +24.4
TBS (T0) 258.8 135.9 0.426 +14.9 400.4 265.0 0.465 7.4 392.3 257.6 0.197 3.3
TBS (T48) 1264 1052.2 0.283 +15.7 566.8 416.7 0.429 8.1 579.2 428.0 0.272 4.1
TBS + RPMI (T60) 1693 1443.3 0.340 12.4 573.7 423.0 0.664 9.3 606.0 452.4 0.218 8.0
TBS + RPMI (T180) 2229 1931.9 0.363 9.3 1142 941.0 0.518 12.4 720.1 556.4 0.376 10.3
U-PS TBS (T-2) 127.6 – 0.008 26.8 127.6 – 0.008 26.8 127.6 – 0.008 26.8
TBS (T0) 136.5 7.0 0.040 26.1 545.6 327.6 0.363 7.0 148.8 16.6 0.055 8.7
TBS (T48) 151.1 18.4 0.100 17.0 2224.0 1642.9 0.328 9.2 134.2 5.2 0.027 8.3
TBS + RPMI (T60) 324.2 154.1 0.262 11.3 1830.0 1334.2 0.229 9.4 153.9 20.6 0.064 10.3
TBS + RPMI (T180) 1037.0 712.7 0.540 7.5 2038.0 1497.2 0.270 9.2 235.4 84.5 0.441 9.4
Z average (Z-AVE), polydispersity index (PDI) and zeta potential (ZP) of polystyrene particles incubated at 37 C at various time points (T-2 to T180).
T-2 represents time point immediately prior to mixing with protein which occurred at T0. Particles – protein suspensions were then incubated for
48 min at 37 C (T48) before the addition of serum-free RPMI cell culture medium (T60). The particles were then incubated for a further two hours
(T180).
aDd¼ (d(t) – d(t-2))/d(t-2). The zeta potential of SP-A in TBS was 10.9 mV at T-2.
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of SP-A or BSA had similar effects in making the U-PS ZPs closer
to zero (Table 1).
Due to the large polydispersity indices for the DLS measure-
ments and the differing results when comparing particle agglom-
eration kinetics, fluorescence microscopy was also used to
examine NP agglomeration in buffered saline with or without
calcium following incubation with SP-A or BSA. The micrographs
show that the U-PS particles remained stable either in the presence
or absence of calcium at physiological temperatures (Figure 2).
The incubation of U-PS particles with SP-A in the absence of
calcium resulted in a small degree of particle agglomeration;
however, this agglomeration was greatly enhanced in the presence
of 2 mM calcium and SP-A (Figure 2). In order to ascertain whether
the effect was specific to SP-A, we performed the experiment with
a similar concentration of BSA and observed no agglomeration
with or without the presence of calcium (Figure 2). A-PS particles
self-agglomerated at physiological temperatures (i.e. 37 C). This
self-agglomeration was inhibited in the presence SP-A in a
calcium-independent manner. However, large agglomerates
were still evident when A-PS particles were incubated with BSA
(Figure 2).
The association of SP-A with A-PS and U-PS particles was
also examined using SDS-PAGE analysis. Particles were
incubated with SP-A for 24 hours at 37 C in TBS containing
calcium or EDTA. The particles were then centrifuged and
washed twice in the appropriate buffer (i.e. TBS containing Ca or
EDTA), and the pellet was examined using reduced SDS-PAGE.
This allowed the determination of the hard (i.e. strongly bound)
SP-A corona. SP-A strongly associated to U-PS particles and the
association independent of calcium. SP-A was found not to
strongly associate with the A-PS particles whether in the presence
of calcium or EDTA (see Figure S4).
Toxicity of U-PS and A-PS NPs
In order to establish whether particle toxicity could influence
cellular uptake of the particles, the effect of the NPs on cellular
toxicity was investigated using the tetrazolium dye (MTT)
colorimetric assay for cellular growth and viability. RAW264.7
cells were incubated with A-PS and U-PS particles in a range
from 1 to 15 cm2/mL and were found not to be toxic to RAW264.7
cells at one hour (A-PS: p¼ 0.85 and U-PS: 0.82, Figure S5).
Following 24 hours of incubation, the A-PS particles reduced
cellular viability (p50.05 for concentrations 3.75 cm2/mL),
whereas no effect was observed for the U-PS particles (p¼ 0.79,
Figure S5). The results of the dose response at 24 hours were
verified with a clonogenic assay, which showed significant
toxicity of the A-PS particles from a concentration of
0.23 cm2/mL (p50.05, Figure S6) but not for the U-PS particles
when compared with no NP particles present (p¼ 0.34,
Figure S6).
A-PS particle association to macrophage-like RAW cells
analysed by coherent anti-Stokes Raman spectroscopy
Imaging with coherent anti-Stokes Raman spectroscopy (CARS)
was used to quantify the association of unlabelled A-PS
particles to the murine macrophage-like RAW 264.7 cells.
Some of the NPs were pre-incubated with SP-A (10 mg/mL) for
an hour before incubating with the cells. Initial experiments
showed that individual 100 nm NPs could not be resolved
with enough specificity using this technique (data not shown).
However, 200 nm A-PS particles were resolvable and there-
fore used in this study. The CARS analysis showed that
SP-A inhibited the association of the A-PS NPs to the cells
(Figure 3A). Quantification of the 200 nm A-PS particles
compared with the area of the cells showed that SP-A signifi-
cantly decreased the association of the A-PS NPs with the cells
(p¼ 0.029, Figure 3B).
NP uptake into RAW cells and mouse AMs analysed
by FACS
To examine the effect of SP-A interaction with 100 nm NPs
specifically on cellular uptake, rather than just cellular associa-
tion, we performed dose-response experiments using a two-fold
serial dilution of SP-A from 20 to 0mg/mL with 100 nm
fluorescent U-PS or A-PS NPs using the macrophage-like cell
line RAW264.7 in the presence of calcium (Figure 4). Following
NP treatment and directly before FACS analysis, the cells were
treated with trypan blue, which quenches the fluorescent signal
outside the cells (Hartshorn et al., 1994). SP-A significantly
increased the uptake of U-PS into the RAW cells at concentrations
of 10 mg/mL (p50.01 with SP-A 10 mg/mL), whereas the
uptake of A-PS was significantly reduced in the presence of SP-A
at concentrations of 0.156 mg/mL (p50.05 at SP-A 0.156 mg/
mL) compared with the absence of SP-A (Figure 4). BSA was
used as a non-specific protein control at a concentration of 20 mg/
mL for both types of particles. BSA caused non-significant
increases in the uptake of both U-PS particles (3.8% increase,
p¼ 0.44) and A-PS particles (9.1% increase, p¼ 0.19; data not
shown).
The effect of SP-A on the uptake of A-PS and U-PS in the AMs
from wild type (WT) and SP-A knock-out mice (SP-A/) was
also examined. An increase in the uptake of 100 nm A-PS
particles in AM from SP-A/ mice was observed when
Figure 2. Effect of SP-A on A-PS and U-PS particle agglomeration. The effect of SP-A (10 mg/mL) in the presence and absence of calcium (2 mM) in
PBS on the agglomeration of 100 nm fluorescent orange-labelled A-PS or 100 nm fluorescent green-labelled U-PS particles (3.8 cm2/mL) was
evaluated using fluorescence microscopy. A-PS and U-PS particles were incubated with or without proteins for one hour at 37 C before being mounted
onto slides for microscopy. Pictures were taken at 400 magnification.
DOI: 10.3109/17435390.2014.992487 SP-A and NPs 957
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 B
irm
ing
ha
m]
 at
 09
:41
 15
 Ja
nu
ary
 20
16
 
compared with AM isolated from WT mice (Figure 5A). No
statistically significant difference was seen when the uptake of
100 nm U-PS particles was compared in AMs from SP-A/ and
WT mice (Figure 5A). Furthermore, no statistically significant
difference was seen in the uptake of either 500 nm U-PS or A-PS
particles in SP-A/ and WT AMs (Figure 5A). This suggests
there might be a dependency on both the size and surface
chemistry of the SP-A inhibition observed for the 100 nm A-PS
particles. We next investigated the effect of exogenous SP-A on
the uptake of 100 nm U-PS and A-PS particles into AMs isolated
from SP-A/ and WT mice. The 100 nm particles were chosen
for the SP-A add back experiments as no significant difference
was observed in the uptake of either the 500 nm A-PS or 500 nm
U-PS particles between WT and SP-A/ mice. Consistent with
the previous experiments, there was a significant increase in the
uptake of 100 nm A-PS particles in SP-A/ macrophages
compared with WT macrophages (p50.002; Figure 5B). The
pre-incubation of exogenous SP-A with A-PS particles decreased
the uptake by AMs from both groups of mice significantly
compared to in the absence of SP-A (p50.001 for both mouse
groups; Figure 5B). An increase was seen in the uptake of 100 nm
U-PS particles by the addition of SP-A to AMs isolated from both
groups of mice, but this did not reach statistical significance
(WT: p¼ 0.26 and SP-A/: p¼ 0.17; Figure 5C).
Discussion
We have previously characterised the interaction between SP-D
and PS particles with different surface modifications (Kendall
et al., 2013). This showed that SP-D differentially interacts with
particles, modifying their uptake by AMs and lung-derived
dendritic cells. The purpose of this study was to investigate
whether SP-A showed differential interaction with PS NPs with
different surface charge and if this interaction affected uptake of
these NPs into macrophages in a similar or complementary way to
SP-D.
NP characterisation
The size of SP-A in water remained stable at around 30 nm, which
is consistent with the literature, where human SP-A has previously
been measured by DLS to be 42 ± 6 nm (Lo´pez-Sa´nchez et al.,
2011) and electron micrographs of recombinant human SP-A
being less than 50 nm in length (Voss et al., 1988).
The incubation of U-PS particles with SP-A or BSA resulted in
the ZPs of the particle suspensions moving closer to zero. This
shows that the addition of protein to the particle suspension
results in a reduction in colloidal stability, a process which
enhances the likelihood of particle agglomeration. This observa-
tion is similar to the findings by Ruge et al (2011), where they
observed that SP-A and BSA had similar effects when incubated
with magnetite NPs with different surface charges. In this study,
SP-A changed the ZP for A-PS particles from a positive to a
negative charge when incubated in TBS with calcium (+24.4 to
7.4 mV) or nanopure water (+60 to 22.8 mV). This is also
similar to the findings by Ruge et al. (2011) when using particles
with a positive ZP.
Protein coronas, which form around NPs, usually consist of an
outer layer of loosely associated proteins termed the ‘‘soft’’
corona and an inner layer of strongly associated proteins called
the ‘‘hard’’ corona (Barran-Berdon et al., 2013; Deng et al.,
2012). Differences in particle agglomeration following incubation
with SP-A may be linked to altered protein association with the
particles. In particle association studies using SDS PAGE, we
found that SP-A formed a hard corona around U-PS but not A-PS
particles (Figure S4). The changes in the DLS and ZP measure-
ments suggest that SP-A forms a soft corona around the A-PS
particles. This shows that differences in the particle surface
chemistry can influence the interaction of SP-A with the particles,
which in turn may influence particle agglomeration and uptake.
Furthermore, this study has shown that although SP-A-mediated
agglomeration of U-PS particles depends on the presence of
calcium, the association of SP-A with these particles is calcium
independent. Although the ZP for both NPs bound by SP-A is
around 20 mV in nanopure water and around 10 mV in TBS,
the agglomeration kinetics are different. The U-PS particles
agglomerated in the presence of SP-A, whereas disagglomeration
Figure 3. The association of 200 nm unla-
belled A-PS with (w) and without (w/o) SP-A
to macrophage-like RAW264.7 cells visua-
lised and quantified by CARS. (A) CARS
images; 200 nm A-PS particles show up as
white particles (arrows). Note that other
–CH2-rich structures, such as the nuclear
membrane, shows up as a visible ring in each
cell (asterisks). (B) CARS images were
analysed using MATLAB software as
described in the materials and methods
section. N¼ 4 per column. Shown is the
mean ± standard derivation. p50.05 was
considered statistically significant.
Figure 4. The effect of exogenous SP-A on the uptake of 100 nm A-PS
and U-PS particles in macrophage-like RAW264.7 cells. Two-fold serial
dilution of SP-A was incubated with fluorescent 100 nm A-PS or U-PS
particles (3.8 cm2/mL) in the presence of calcium before incubating with
RAW cells. Extra cellular association of NPs with cells were quenched
using trypan blue. The particle uptake was analysed using FACS. Shown
are the mean ± standard derivation of four independent experiments.
*p50.05 and ****p50.0001.
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occurred for A-PS particles. This again implies a differential SP-
A-binding mechanism for these two types of particle. SP-A has
been reported to self-agglomerate under certain conditions.
Binding of SP-A to U-PS particles could facilitate conform-
ational changes in SP-A that would enhance protein self-
agglomeration or agglomeration of the U-PS particles. In the
case of A-PS particles, the results indicate that the presence of the
SP-A molecule at the particle surface may block the sites on the
particle involved in self-agglomeration. SP-A would thereby
inhibit A-PS self-agglomeration. The degree to which this is an
SP-A-specific effect is unclear as BSA also inhibits A-PS
agglomeration. Further work examining the particle agglomer-
ation kinetics following SP-A incubation is necessary using
techniques that allow the accurate quantification of particle size in
highly polydispersed suspensions.
SP-A-mediated agglomeration of U-PS is dependent on
calcium concentration
We found that a minimum concentration of 2 mM calcium was
required for SP-A to agglomerate the 100 nm U-PS particles
(Figure S3). This minimum calcium concentration is consistent
with findings reported by Haagsman et al. (1990) who observed
that SP-A became saturated with calcium around a free calcium
concentration of 2 mM. This also agrees with structural findings
reported for the recombinant fragment of human SP-D, where this
calcium concentration was thought to act like a molecular switch
in the lectin-binding site (Shrive et al., 2003). These findings
indicate that the CRD may be involved in the agglomeration of the
U-PS particles. Calcium is required to stabilise the conformation
of the lectin-binding domain (Head et al., 2003). By using the
structure of trimeric fragment of rat SP-A and computer
modelling, Head et al. (2003) showed that the electrostatic
surface of the CRD of the SP-A becomes less negatively charged
when calcium is present in the CRD. The SP-A-induced
agglomeration of NPs might not directly involve the actual
lectin binding site in the CRD region, but the overall conform-
ation or electrostatic surface charge induced by calcium could
result in a differential interaction than that seen in the absence of
calcium. We have previously shown that a recombinant fragment
of SP-D, containing a trimeric unit of neck and CRD regions only
(Figure S1), is enough to interact with the particles used in
this study (Kendall et al., 2013). It therefore seems plausible to
extend this finding to SP-A. SP-A would, by crosslinking
individual particles via individual trimeric units, be able to
agglomerate NPs. These results also show that SP-A has a
different interaction with surface-modified NPs compared with
native SP-D. SP-A inhibits the agglomeration of A-PS particles,
whereas SP-D facilitates A-PS particle agglomeration. Both SP-A
and SP-D agglomerated U-PS particles in the presence of calcium
(summarised in Figure 6A).
NP toxicity
We show here that the used A-PS and U-PS particles were not
toxic to the RAW 264.7 cells over short incubation periods such
as those used in the in vitro cellular experiments (Figure S5 and
S6). The observed difference between in the effect of SP-A on A-
PS and U-PS particles is therefore not due to the toxicity of short-
term exposure of the cells with the NPs. However, when
extending the incubation period from 1 hour to 24 hours, the A-
PS particles did show toxic effects on the cells, while no toxic
effect was observed for the U-PS particles. This is consistent with
previous reports where it was observed that A-PS, but not U-PS,
particles had a toxic effect on the TT1 cell line, a human alveolar
epithelial type I like cell line (Ruenraroengsak et al., 2012). This
highlights the difference between the ‘‘high dose–short expos-
ure’’ acute toxicity models often used in in vitro assays and real-
life exposure scenarios where there is often low concentration of
NPs but a long/chronic exposure period.
Figure 5. Uptake of U-PS and A-PS and the
effects of 10mg/mL SP-A on the uptake by
alveolar macrophages isolated from wild-type
and SP-A/ mice. (A) Uptake of FITC
labelled 100 and 500 nm U-PS and A-PS
particles (5:1 NP/cell) by AMs isolated from
wild type mice (light grey) and SP-A/ mice
(dark grey). (B) Fluorescent orange-labelled
100 nm A-PS (3.8 cm2/mL) in the absence
(light grey) of presence (dark grey) of SP-A
with AMs from wild-type mice and SP-A/
mice. (C) Fluorescent green-labelled 100 nm
U-PS (3.8 cm2/mL) in the absence (light
grey) or presence (dark grey) of SP-A with
AMs from wild-type mice and SP-A/ mice.
The statistical analysis was determined using
unpaired t-test as described in the materials
and method section. p50.05 was considered
statistical significant and significant values
are shown in the figure. Data show relative
mean fluorescence intensity (MFI) ± standard
derivation derived from three (Figure 5A
and B) and two (Figure 5C) independent
experiments with n¼ 3 mice per experiment.
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SP-A promotes or inhibits cellular uptake of NPs
depending on the surface chemistry and size of particle
Macrophage-like RAW264.7 cells were used to investigate the
interactions of SP-A with NPs on phagocytic NP uptake. We
found that SP-A enhanced the uptake of U-PS particles in a dose-
dependent manner, but inhibited the uptake of A-PS particles. To
investigate this further, we isolated AMs from SP-A/ mice,
which would have no SP-A associated with them and compared
them with AMs from WT mice, that would have SP-A associated
with them. SP-A/ AMs were not deficient in uptake of 100 nm
or 500 nm U-PS or 500 nm A-PS particles compared with the
control WT AMs. However, there was a significantly increased
uptake of 100 nm A-PS into AMs isolated from SP-A/ mice
compared with WT AMs. The interaction was further confirmed
by coating NPs with SP-A prior to incubation with AMs isolated
from SP-A/ and WT mice, respectively, showing that SP-A
inhibited the uptake of A-PS particles by cells from both groups
of mice. The reduction of macrophage clearance of 100 nm A-PS
particles following pre-incubation of SP-A could be mediated, at
least in part, through the inhibition of A-PS self-agglomeration at
physiological temperatures. However, BSA also showed the
ability to inhibit A-PS agglomeration but had little effect on the
uptake of A-PS particles by RAW cells. This finding coupled with
the enhanced uptake of A-PS particles by AM from SP-A/ mice
suggests that mechanisms other than the inhibition of A-PS
agglomeration may be involved in the SP-A-mediated reduction of
A-PS uptake. The reduction in phagocytic clearance of potentially
toxic particles may result in enhanced exposure or damage to the
alveolar epithelium and/or increased translocation to extrapul-
monary sites through the systemic circulation. We have previously
shown that exogenous SP-D can enhance the uptake of 100 nm A-
PS particles by AMs from SP-D-deficient mice (Kendall et al.,
2013). It would therefore be interesting to determine in future
experiments whether the presence of SP-D could alter the ability
of SP-A to inhibit the clearance of these particles by AMs.
Potential impact in vivo
It is thought that NPs move by diffusion and pass through the
trachea bronchiolar region into the alveoli, where they are
deposited and may remain for some time (Muhlfeld et al., 2008).
Once they enter the surfactant hypophase, they have the oppor-
tunity to interact with surfactant lipids and proteins such as SP-A
and SP-D (Figure 6B). Lipids and proteins absorb onto the
particle surface forming coronas (Walkey et al., 2012). This bio-
corona leads to changes in surface chemistry and colloidal
stability (Ruge et al., 2012). The particles may be directly taken
up by AMs (Erpenbeck et al., 2005; Geiser et al., 2008). However,
changes to surface chemistry could result in different pattern
recognition by defence molecules or surface receptors on cells and
could therefore potentially influence the fate of nanomaterials. As
SP-A and SP-D show differential interaction with the particles
used in this article, the two proteins could potentially complement
each other in vivo.
It has been shown that both lipids and proteins from surfactant
interact with NPs (Bakshi et al., 2008; Kendall, 2007). In order to
create a more realistic in vitro model of in vivo conditions, it
would be beneficial to include lipids in these models for future
experiments. Ruge et al. (2012) looked at SP-A and SP-D with
metal-NPs with different surface coatings and found differential
effects of SP-A and SP-D. They also observed that incorporating
surfactant lipids into the in vitro models modified the effects of
SP-A and SP-D (Ruge et al., 2012). This highlights the fact that
current in vitro models do not reflect what happens in vivo.
Human BAL can agglomerate NPs (Kendall et al., 2002). An
in vitro model using the natural porcine surfactant preparation
Curosurf (devoid of SP-A and SP-D) also modified the effect of
multi-walled carbon nanotubes and enhanced their oxidative and
pro-inflammatory effects (Gasser et al., 2012). In order to have a
comprehensive understanding of how NPs interact with both
surfactant proteins and lipids, it is important to understand how
NPs interact not only with specific subcomponents of surfactant
but also implementing a model system that resembles in vivo
circumstances as recently highlighted by Schleh et al. (2013).
Agglomeration seems to be the key to enhanced uptake into
AMs in these observations and the surface chemistry described
provides a mechanism for agglomeration by SP-A. However, SP-
A provides important immune functions within the airspace and
sequestering by NPs may leave an individual vulnerable to other
pathogenic events and uncontrolled inflammation. We have
Figure 6. The role of collectins in agglomeration of NPs. (A) Differential interaction of SP-A, SP-D and rfhSP-D with 100 nm U-PS and A-PS
particles. Both SP-A and SP-D agglomerates U-PS particles in the presence of calcium. A-PS particles tend to self-agglomerates at 37 C but SP-A
inhibits that by binding to the particles, whereas SP-D facilitates further agglomeration. The rfhSP-D binds to both A-PS and U-PS particles but does
not facilitate agglomeration of the particles as seen with native SP-D (Kendall et al., 2013). The NPs, SP-A, SP-D and rfhSP-D are approximately to
scale. (B) Simplistic model showing the roles of SP-A and SP-D and NP clearance in vivo in the alveolar space. Inhaled particles enter the alveolar
space (1) and deposit onto the air-liquid interface of the alveolus (2). The particles are then displaced into the fluid phase through wetting forces,
resulting in the formation of a lipid biocorona (3). The biocorona is then modified through the incorporation of surfactant proteins, potentially resulting
in particle agglomeration dependent on the surface chemistry of the particle (4). Particle agglomerates are recognised by alveolar macrophages (5) and
phagocytosed (6). ATI, alveolar epithelial type I cells; ATII, alveolar epithelial type II cells. Model not to scale.
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previously shown that three different types of carbon black
particles, ranging from 25 to 75 nm in diameter, were able to
completely eliminate SP-D from a suspension (Kendall et al.,
2004). Furthermore, an animal study exposing rats infected with
Streptococcus pneumoniae to PM2.5 particles resulted in an
exacerbation of the on-going infection (Zelikoff et al., 2003). We
have recently shown that incubating these NPs with SP-A and
SP-D alters the ability of these proteins to neutralise influenza
A infection in vitro (McKenzie et al., 2015). This implies that
sequestering immune-related proteins could result in functionally
deficient individuals resulting in an increase in their susceptibility
towards bacterial and viral infections and other inflammatory
conditions as observed in mice deficient for SP-A or SP-D
(Hawgood et al., 2004; LeVine & Whitsett, 2001; Li et al., 2002).
It is therefore important that more research is performed to
elucidate the implications of the interactions between SP-A and
-D and NPs in order to evaluate the potential health implications
when implementing the usage of NPs in the working environment
and everyday modern consumer products.
Conclusions
In this study, we have characterised the interaction between NPs
and SP-A, examined the effect on cellular uptake, and propose
uptake mechanics into macrophages. SP-A showed material-
specific binding and calcium-dependent agglomeration of U-PS
NPs. We showed that SP-A inhibited the uptake of 100 nm A-PS
NPs into macrophage-like cells and primary AMs using CARS
(unlabelled 200 nm NPs) and FACS (fluorescent NPs), but this
was not observed for larger (500 nm) A-PS particles.
This study combined with previous studies with SP-A and
SP-D shows that these molecules may have a (complementary)
role in clearing non-pathogen particulate and nanoparticulate
materials in vivo. An important factor, when examining the
interaction of SP-A or SP-D with NPs, is to consider how the
interplay between surfactant lipids and proteins in the bio-corona
will affect the interaction and the subsequent downstream
bioavailability of the collectins. Future in vivo studies focusing
on the interaction between these lung collections, NPs and the
clearance route(s) into cells and body compartments is required to
provide further insight into the role(s) of SP-A and SP-D in
response to inhalation of NPs.
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